Literature DB >> 29070009

Editorial: New Therapetic Approaches in the Management of Ischemia Reperfusion Injury and Cardiometabolic Diseases: Opportunities and Challenges.

Jun Ren1, Yingmei Zhang2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29070009     DOI: 10.2174/138945011815171019092703

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


× No keyword cloud information.
  5 in total

Review 1.  Physical Exercise and Selective Autophagy: Benefit and Risk on Cardiovascular Health.

Authors:  Ne N Wu; Haili Tian; Peijie Chen; Dan Wang; Jun Ren; Yingmei Zhang
Journal:  Cells       Date:  2019-11-14       Impact factor: 6.600

2.  MiR-21-5p-expressing bone marrow mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury by regulating the circRNA_0031672/miR-21-5p/programmed cell death protein 4 pathway.

Authors:  Jing Zhang; Chang-Jun Luo; Xiao-Qi Xiong; Jun Li; San-Hua Tang; Lin Sun; Qiang Su
Journal:  J Geriatr Cardiol       Date:  2021-12-28       Impact factor: 3.327

3.  Cardiovascular medicine in the era of COVID-19 pandemics.

Authors:  Jun Ren
Journal:  Cardiol Plus       Date:  2021-12-30

4.  PERK Overexpression-Mediated Nrf2/HO-1 Pathway Alleviates Hypoxia/Reoxygenation-Induced Injury in Neonatal Murine Cardiomyocytes via Improving Endoplasmic Reticulum Stress.

Authors:  Jichun Wang; Li Lu; Sisi Chen; Jing Xie; Shuai Lu; Yanli Zhou; Hong Jiang
Journal:  Biomed Res Int       Date:  2020-03-26       Impact factor: 3.411

Review 5.  The Role of Mitochondrial Quality Control in Cardiac Ischemia/Reperfusion Injury.

Authors:  Jia Huang; Ruibing Li; Chengbin Wang
Journal:  Oxid Med Cell Longev       Date:  2021-06-09       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.